Pfizer's stock is down roughly 60% from its late 2021 highs, but the drug giant is working to innovate its way back into the ...

BRUSSELS (Reuters) - The European Union reached a deal with Pfizer and BioNTech for 300 million additional doses of their COVID-19 vaccine, the head of the European Commission said on Friday, in a ...

I was taken aback to hear the government had selected GC Biopharma as a company to support in phase 1 (first-stage clinical ...

With flu season underway and new, developing COVID-19 strains, health professionals continue to stress the importance of receiving an updated vaccine. On Oct. 23, the Centers for Disease Control and ...

The study will examine vaccine safety, efficacy and immunity at lower doses. Pfizer is advancing Phase 2/3 clinical trials for young kids at lower doses than vaccines for adults, the pharmaceutical ...

The vaccine needs to be stored at around -70 degrees Celsius. Early data revealed Monday that Pfizer's COVID-19 vaccine candidate could be up to 90% effective. The company still needs to submit its ...

Under Robert F. Kennedy Jr., federal officials may withdraw an endorsement for the vaccine in younger children. By Apoorva Mandavilli This fall, it may not be possible for many parents to have a ...

The pharmaceutical company filed its application with the FDA on May 7, and the FDA is expected to finish its approval process by Labor Day weekend.

Pfizer stock (NYSE: PFE) currently trades at $28 per share, 55% below its peak level of $61 seen in December 2021. In contrast, Merck stock (NYSE:MRK) is up 36% over this period. PFE stock was trading ...

The CEO of BioNTech Ugur Sahin was inoculated in early 2021 with the COVID-19 vaccine his team developed with Pfizer, a company spokesperson told Reuters, contrary to social media posts sharing an ...